ENVA:NYSEEnova International, Inc. Analysis

Enova International (ENVA) trades around $135.9, well below its DCF‑derived fair value and the 42% upside indicated by the model, positioning it as a clear undervalued play. Key valuation metrics such as a trailing P/E of 11.8 versus the industry average of 16.5 and a forward P/E of 7.2 underscore the discount, while the price‑to‑book of 2.5 remains reasonable given a book value of $54 per share. Technical indicators are mixed: the 20‑day SMA (136.68) sits just above the current price, the RSI at 45 suggests neutral momentum, and the MACD histogram has turned positive, hinting at a potential short‑term rebound from the $129.25 support level. Recent news notes that the stock is technically oversold and analysts have upgraded earnings forecasts, reinforcing the upside thesis.
Fundamentally, ENVA delivers robust financial performance with 22.9% revenue growth, an 82.7% gross margin, and a 20.6% profit margin, translating into a strong ROE of 24.3%. However, the balance sheet is leveraged, reflected by a debt‑to‑equity ratio of 339% and a beta of ~1.3, which elevates sector and regulatory risk. Volatility remains high at ~41% over the past 30 days, and trading volume is modest, indicating liquidity constraints. Balancing the attractive valuation and growth profile against the debt load and regulatory environment suggests a nuanced investment approach.